Effect of Prolactin on Growth and the Estrogen Receptor Level of Human Breast Cancer Cells (MCF-7)

Cancer Research

Volumn 37, Issue 3, 1977, Pages 792-799

  Shafie, Samir ^a,c   Brooks, S C ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CYCLIC AMP; DRUG RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; INSULIN; PROLACTIN; RADIOISOTOPE; THEOPHYLLINE;

BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; DNA SYNTHESIS; ESTRADIOL H 3; IN VITRO STUDY; MAJOR CLINICAL STUDY; THEORETICAL STUDY;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BREAST NEOPLASMS; BUCLADESINE; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; CYCLIC AMP; CYTOSOL; DNA, NEOPLASM; DRUG INTERACTIONS; ESTRADIOL; HUMAN; INSULIN; NEOPLASM PROTEINS; PROLACTIN; PROTEIN BINDING; RECEPTORS, ESTROGEN; SUPPORT, U.S. GOV'T, P.H.S.; THEOPHYLLINE;

EID: 0017345887     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Baxter, J. D., Higgins, S. J., and Rousseau, G. G. Measurement of Specific Binding of a Ligand in Intact Cells: Dexamethasone Binding by Cultured Hepatoma Cells. Methods Enzymol. 36 (Part A): 240-248, 1975.
2. Blobel, G., and Potter, V. R. Nuclei from Rat Liver: Isolation Method that Combines Purity with High Yield. Science, 154: 1662–1665, 1966.
3. Brooks, S. C., Locke, E. R., and Soule, H. D. Estrogen Receptor in a Human Cell Line (MCF-7) from Breast Carcinoma. J. Biol. Chem., 248: 6251–6253, 1973.
4. Burton, K. A Study of the Conditions and Mechanism of the Diphenylamine Reaction for the Colorimetric Estimation of Deoxyribonucleic Acid. Biochem. J., 62: 315–323, 1956.
5. Cho-Chung, Y. S. In Vivo Inhibition of Tumor Growth by Cyclic Adenosine 3‘,5’-Monophosphate Derivatives. Cancer Res., 34: 3492-3496,1974.
6. Chung, Y. S., and Caullino, P. M. In Vivo Inhibition of Growth of Two Hormone-Dependent Mammary Tumors by Dibutyryl Cyclic AMP. Science, 183: 87–88, 1974.
7. Ellis, D. J., and Ringold, H. J. The Uterine Estrogen Receptor: A Physicochemical Study. In: K. W. McKerns (ed.), The Sex Steroids, pp. 73–106. New York: Appleton-Century-Crofts, 1971.
8. Godefroi, V. C., and Brooks, S. C. Improved Gel-Filtration Method for Analysis of Estrogen Receptor Binding. Anal. Biochem., 51: 335–344, 1973.
9. Gorski, J., Sarff, M., and Clark, J. The Regulation of Uterine Concentration of Estrogen Binding Protein. In: G. Raspe (ed.), Advances in the Biosciences, Vol. 7. Schering Workshop on Steroid Hormone “Receptors,” pp. 5–15. Oxford: Pergamon Press, 1971.
10. Hähnel, R., and Twaddle, E. Estimation of the Association Constant of the Estrogen-Receptor Complex in Human Breast Cancer. Cancer Res., 33: 559–566, 1973.
11. Higuchi, K., and Robinson, R. C. Studies on the Cultivation of Mammalian Cell Lines in a Serum-free, Chemically Defined Medium. In Vitro, 9: 114–121, 1973.
12. Honn, K. V., Singley, J. A., and Chavin, W. Fetal Bovine Serum. A Multivariate Standard. Proc. Soc. Exptl. Biol. Med., 149: 344-347, 1975.
13. Horwitz, K. B., Costlow, M. E., and McGuire, W. L. MCF-7: A Human Breast Cancer Cell Line with Estrogen, Androgen, Progesterone, and Glucocorticoid Receptors. Steroids, 26: 785–795, 1975.
14. Jensen, E. V., Block, G. E., Smith, S., Kyser, K., and Desombre, E. R. Estrogen Receptors and Breast Cancer Responses to Adrenalectomy. Prediction of Response in Cancer Therapy. Natl. Cancer Inst. Monograph, 34: 55–70, 1971.
15. Jensen, E. V., Brecher, P. I., Numata, M., Smith, S., and Desombre, E. R. Estrogen Interaction with Target Tissues: Two-step Transfer of Receptor to the Nucleus. Methods Enzymol., 36 (Part A): 267–275, 1975.
16. Jensen, E. V., and Desombre, E. R. Mechanism of Action of the Female Sex Hormones. Ann. Rev. Biochem., 41: 203–230, 1972.
17. Jensen, E. V., Numata, M., Brecher, P. I., and Desombre, E. R. Hormone-Receptor Interaction as a Guide to Biochemical Mechanism. In: R. M. S. Smellie (ed.), The Biochemistry of Steroid Hormone Action, pp. 133–159. New York: Academic Press, Inc., 1971.
18. Leung, B. S., and Sasaki, G. H. Prolactin and Progesterone Effect on Specific Estradiol Binding in Uterine and Mammary Tissues in Vitro. Biochem. Biophys. Res. Commun., 55: 1180–1187, 1973.
19. Lippman, M. E., and Bolan, G. Estrogen-Responsive Human Breast Cancer in Long-term Tissue Culture. Nature, 256: 592–593, 1975.
20. Lippman, M. E., Bolan, G., and Huff, K. Human Breast Cancer Responsive to Androgen in Long-term Tissue Culture. Nature, 258: 339–341, 1975.
21. Lippman, M. E., Monaco, M. E., and Pinkus, L. Estradiol Induces Thymidine Kinase Activity in Estrogen Responsive Human Breast Cancer in Continuous Tissue Culture. In: Abstracts of the 58th Meeting, The Endocrine Society, San Francisco, 1976, p. 122.
22. Little, M., Szendro, P., and Jungblut, P. W. Interrelationship of Two Microsomal Estrogen Receptor Molecules. Acta Endocrinol. Suppl., 183: 67–69, 1973.
23. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein Measurement with the Folin Phenol Reagent. J. Biol. Chem., 193: 265–275, 1951.
24. Matusik, R. J., and Hilf, R. Relationship of Adenosine 3‘,5’-Cyclic Monophosphate and Guanosine 3‘,5’-Cyclic Monosphosphate to Growth of Dimethylbenz[a]anthracene-lnduced Mammary Tumors in Rats. J. Natl. Cancer Inst., 56: 659–661, 1976.
25. McGuire, W. L. Estrogen Receptors in Human Breast Cancer. J. Clin. Invest., 52: 73–77, 1973.
26. McGuire, W. L., Carbone, P. P., and Vollmer, E. P. Estrogen Receptors in Human Breast Cancer, pp. 1–275. New York: Raven Press, 1975.
27. McGuire, W. L., and De LaGarza, M. Improved Sensitivity in the Measurement of Estrogen Receptor in Human Breast Cancer. J. Clin. Endocrinol. Metab., 37: 986–989, 1973.
28. Meites, J., and Nicoll, C. S. Adenohypophysis: Prolactin, Ann. Rev. Physiol. 28: 57–88, 1966.
29. Mester, J., Robertson, D. M., Feherty, P., and Kellie, A. E. Determination of High-Affinity Estrogen Receptor Sites in Uterine Supernatant Preparations. Biochem. J., 120: 831–836, 1970.
30. Munck, A., and Wira, C. Methods for Assessing Hormone-Receptor Kinetics with Cells in Suspension: Receptor-bound and Nonspecifically Bound Hormone: Cytoplasmic-Nuclear Translocation. Methods Enzymol., 36 (Part A): 255–264, 1975.
31. O'Malley, B. W., and Means, A. R. Female Steroid Hormones and Target Cell Nuclei. Science, 183: 610–620, 1974.
32. Osborne, C. K., and Lippman, M. E. Insulin-Responsive Human Breast Cancer in Long-term Tissue Culture. Proc. Am. Assoc. Cancer Res., 17: 209, 1976.
33. Pearson, O. H. Endocrine Aspects of Breast Cancer. In: C. B. Anfinsen, M. Potter, and A. N. Schechter (eds.), Current Research in Oncology, pp. 125–141. New York: Academic Press, Inc., 1972.
34. Pearson, O. H., Lierena, O., Lierena, L., Molina, A., and Butler, T. Prolactin-Dependent Rat Mammary Cancer: A Model for Man? Trans. Assoc. Am. Physicians, 32: 225–239, 1969.
35. Pearson, O. H., Molina, A., Butler, T., Lierena, L., and Nast, H. Estogens and Prolactin in Mammary Cancer. In: T. L. Dao (ed.), Estrogen Target Tissue and Neoplasia, pp. 287–305, Chicago: University of Chicago Press, 1972.
36. Robinson, G. A., Butcher, R. W., and Sutherland, E. W. Cyclic AMP, pp. 1–531. New York: Academic Press, Inc., 1971.
37. Rose, H. N., and McGrath, C. M. a-Lactalbumin Production in Human Mammary Carcinoma. Science, 190: 673–675, 1975.
38. Scatchard, G. The Attraction of Proteins for Small Molecules and Ions. Ann. N. Y. Acad. Sci., 31: 660–672, 1949.
39. Shafie, S. M. Some Hormonal Interactions in the Human Breast Cancer Cells, MCF-7. Ph.D. Dissertation, Wayne State University, Detroit, Mich., 1976.
40. Shafie, S. M., and Brooks, S. C. The Relationship of Insulin to Regulation of Breast Tumor Cells by 17β-Estradiol. In: Abstracts of the 67th Meeting of the American Society of Biological Chemists, San Francisco, 1976, p. 1628.
41. Shafie, S. M., and Brooks, S. C. Characteristics of the Estradiol Receptor (E 2 R) Assay in Breast Tumor Preparations. Proc. Am. Assoc. Cancer Res., 17: 124, 1976.
42. Sherman, M. R. Physical-Chemical Analysis of Steroid Hormone Receptors. Methods Enzymol., 36 (Part A): 211–234, 1975.
43. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. A Human Cell Line from a Pleural Effusion Derived from a Breast Carcinoma. J. Natl. Cancer Inst., 51: 1409–1416, 1973.
44. Sutherland, E. W., Robinson, G. A., and Butcher, R. W. Some Aspects of the Biological Role of Adenosine 3‘:5’-Monophosphate (Cyclic AMP). Circulation, 37: 279–306, 1968.
45. Turkington, R. W. Hormonal Regulation of Mammary Gland Development In Vitro. In: K. W. McKerns (ed.), The Sex Steroids, pp. 383–410. New York: Appleton-Century-Crofts, 1971.
46. Turkington, R. W. Multiple Hormonal Interactions. The Mammary Gland. In: G. Litwack (ed.), Biochemical Actions of Hormones pp. 55–80. New York: Academic Press, Inc., 1972.
47. Vignon, F., and Rochefort, H. Regulation des “Recepteurs” des Oestrogines dans les Tumeurs Mammaires: Effect de la Prolactine in Vivo. Compt. Rend. Acad. Sci. Paris, 278: 103–106, 1974.
48. Vignon, F., and Rochefort, H. Regulation of Estrogen Receptors in Ovarian-Dependent Rat Mammary Tumors. I. Effects of Castration and Prolactin. Endocrinology, 98: 722–729, 1976.
49. Welsch, C. W. Effect of Brain Lesions on Mammary Tumor Genesis. In: T. L. Dao (ed.), Estrogen Target Tissues and Neoplasia, pp. 317–331. Chicago: University of Chicago Press, 1972.
50. Williams, D., and Gorski, J. Preparation and Characterization of Free Cell Suspensions from the Immature Rat Uterus. Biochemistry, 12: 297–306, 1973.
51. Williams, D., and Gorski, J. Equilibrium Binding of Estradiol by Uterine Cell Suspensions and Whole Uteri in Vivo. Biochemistry, 13: 5537–5542, 1974.
52. Williams, D., and Gorski, J. Techniques for Monitoring the Distribution of the Estradiol-Binding Protein Complex between Cytoplasm and Nucleus of Intact Cells. Methods Enzymol., 36 (Part A): 275–283, 1975.
53. Zava, D. T., and McGuire, W. L. An Unusual Subcellular Distribution of Estrogen Receptor in a Human Breast Cancer Cell Line. In: Abstracts of the 58th Meeting, The Endocrine Society, San Francisco, 1976, p. 122.